- 1146/annurev.immunol.22.012703.104614. PMID 15032591.
Fischer A, Hacein-Bey S,
Cavazzana-Calvo M (2002). "Gene
therapy of
severe combined immunodeficiencies"....
-
Marina Cavazzana is a
professor of
Paediatric Immunology at the Necker-Enfants
Malades Hospital and the
Imagine Institute, as well as an
academic at Paris...
-
trials were
based in
Paris and led by
researchers Alain Fischer and
Marina Cavazzana-Calvo.
Whilst the
experiment initially seemed successful, many of the...
-
rhabdomyosarcoma is a
subtype of
embryonal rhabdomyosarcoma first described by
Cavazzana,
Schmidt and
Ninfo in 1992. This
subtype has a more
favorable clinical...
- Sung-Yun; Haddad, Elie; Lisa, Antonella; Hambleton, Sophie; Slatter, Mary;
Cavazzana-Calvo, Marina; Mahlaoui, Nizar; Picard, Capucine; Torgerson, Troy R.;...
-
Human Genome Research Institute. 2009.
Fischer A, Hacein-Bey-Abina S,
Cavazzana-Calvo M (June 2010). "20
years of gene
therapy for SCID".
Nature Immunology...
- (948): 560–70. doi:10.1136/pgmj.2003.017764. PMC 1743106. PMID 15466989.
Cavazzana-Calvo M,
Fischer A (June 2007). "Gene
therapy for
severe combined immunodeficiency:...
-
bubble babies) and
curative approaches using gene therapies. With
Marina Cavazzana-Calvo and
Salima Hacein-Bey, he
obtained in 1999, the
first clinical successes...
- in Paris, France, were
published in the
journal Nature by Drs.
Marina Cavazzana-Calvo and
Philippe Leboulch,
scientific founder of
Genetix Pharmaceuticals...
-
Leiva L,
Sorensen R,
Wulffraat N,
Blanche S,
Bushman FD,
Fischer A,
Cavazzana-Calvo M (September 2008). "Insertional
oncogenesis in 4
patients after...
